Association of the CCR5 gene with juvenile idiopathic arthritis

Genes and Immunity

Volumn 11, Issue 7, 2010, Pages 584-589

  Hinks, A ^a   Martin, P ^a,c   Flynn, E ^a   Eyre, S ^a   Packham, J ^b   Barton, Anne ^a,c   Worthington, J ^a   Thomson, W ^a   Baildam, Eileen ⁱ   Brown, Lynsey ⁱ   Buckley, Joanne ⁱ   Chieng, Alice ⁱ   Davidson, Joyce ⁱ   Eltringham, Michael ⁱ   Foster, Helen ⁱ   Friswell, Mark ⁱ   Gardner Medwin, Janet ⁱ   Gilbert, Paul ⁱ   Hyrich, Kimme ⁱ   Jones, Julie ⁱ   Lal, Sham ⁱ   Lay, Mark ⁱ   Lydon, Carol ⁱ   Meijer, Alexandra ⁱ   Price, Vicki ⁱ   Sim, Jane ⁱ   Todd, Maureen ⁱ   Ward, Peter ⁱ   Wedderburn, Lucy ⁱ   Eyre, Stephen ^c   Hinks, Anne ^c   Gibbons, Laura J ^c   Bowes, John ^c   Flynn, Edward ^c   Ke, Xiayi ^c   Donn, Rachelle ^c   Thomson, Wendy ^c   Worthington, Jane ^c   Martin, Stephen ^d   Robinson, James I ^d   Morgan, Ann W ^d   Wilson, Anthony G ^e   Steer, Sophia ^f   Hocking, Lynne ^g   Reid, David M ^g   Harrison, Pille ^h   Wordsworth, Paul ^h   Abinum, M ⁱ   Becker, M ⁱ   Bell, A ⁱ   Craft, A ⁱ   Crawley, E ⁱ   David, J ⁱ   Foster, H ⁱ   Gardener Medwin, J ⁱ   Griffin, J ⁱ   Hall, A ⁱ   Hall, M ⁱ   Herrick, A ⁱ   Hollingworth, P ⁱ   Holt, L ⁱ   Jones, S ⁱ   Pountain, G ⁱ   Ryder, C ⁱ   Southwood, T ⁱ   Stewart, I ⁱ   Venning, H ⁱ   Wedderburn, L ⁱ   Woo, P ⁱ   Wyatt, S ⁱ   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HAYWOOD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF ABERDEEN   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ NONE

Author keywords

CCR5; chemokine; juvenile idiopathic arthritis

Indexed keywords

CHEMOKINE RECEPTOR CCR5;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; JOINT DESTRUCTION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNOVITIS; SYNOVIUM;

EID: 77958153770     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2010.25     Document Type: Article

References (36)

1. Murray K, Thompson SD, Glass DN. Pathogenesis of juvenile chronic arthritis: genetic and environmental factors. Arch Dis Child 1997; 77: 530-534.
2. Wedderburn LR, Robinson N, Patel A, Varsani H, Woo P. Selective recruitment of polarized Tcells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 2000; 43: 765-774.
3. Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 344-345.
4. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270: 1811-1815.
5. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999; 11: 553-559.
6. Desmetz C, Lin YL, Mettling C, Portales P, Noel D, Clot J et al. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes. Clin Immunol 2007; 123: 148-154.
7. Venkatesan S, Petrovic A, Van Ryk DI, Locati M, Weissman D, Murphy PM. Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration. J Biol Chem 2002; 277: 2287-2301.
8. Garred P, Madsen HO, Petersen J, Marquart H, Hansen TM, Freiesleben SS et al. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol 1998; 25: 1462-1465.
9. Gomez-Reino JJ, Pablos JL, Carreira PE, Santiago B, Serrano L, Vicario JL et al. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum 1999; 42: 989-992.
10. Pokorny V, McQueen F, Yeoman S, Merriman M, Merriman A, Harrison A et al. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 487-490.
11. Zapico I, Coto E, Rodriguez A, Alvarez C, Torre JC, Alvarez V. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes Immun 2000; 1: 288-289.
12. Cooke SP, Forrest G, Venables PJ, Hajeer A. The delta32 deletion of CCR5 receptor in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1135-1136.
13. Prahalad S. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis. Genes Immun 2006; 7: 264-268.
14. Prahalad S, Bohnsack JF, Jorde LB, Whiting A, Clifford B, Dunn D et al. Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun 2006; 7: 468-475.
15. Lindner E, Nordang GB, Melum E, Flato B, Selvaag AM, Thorsby E et al. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Genet 2007; 8: 33.
16. Scheibel I, Veit T, Neves AG, Souza L, Prezzi S, Machado S et al. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases. Scand J Rheumatol 2008; 37: 13-17.
17. Hinks A, Worthington J, Thomson W. The association of PTPN22 with rheumatoid arthritis and juvenile idiopathic arthritis. Rheumatology (Oxford) 2006; 45: 365-368.
18. Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E et al. Overlap of disease susceptibility loci for rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Ann Rheum Dis (e-pub ahead of print 11 August 2009).
19. Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E et al. Association of the AFF3 gene and IL2/IL21 gene region with juvenile idiopathic arthritis. Genes Immun 2010; 11: 194-198.
20. Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359: 2767-2777.
21. Rossol M, Pierer M, Arnold S, Keysser G, Burkhardt H, Baerwald C et al. Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis. Arthritis Res Ther 2009; 11: R91.
22. Zuniga JA, Villarreal-Garza C, Flores E, Barquera R, Perez-Hernandez N, Montes de Oca JV et al. Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans. Clin Exp Rheuma-tol 2003; 21: 351-354.
23. John S, Smith S, Morrison JF, Symmons D, Worthington J, Silman A et al. Genetic variation in CCR5 does not predict clinical outcome in inflammatory arthritis. Arthritis Rheum 2003; 48: 3615-3616.
24. Yang YF, Tomura M, Iwasaki M, Mukai T, Gao P, Ono S et al. IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells. J Clin Immunol 2001; 21: 116-125.
25. Zou W, Foussat A, Houhou S, Durand-Gasselin I, Dulioust A, Bouchet L et al. Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2. ANRS 048 IL-2 Study Group. AIDS 1999; 13: 455-463.
26. Weissman D, Dybul M, Daucher MB, Davey Jr RT, Walker RE, Kovacs JA. Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo. J Infect Dis 2000; 181: 933-938.
27. Heredia A, Amoroso A, Davis C, Le N, Reardon E, Dominique JK et al. Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: an approach to suppress R5 strains of HIV-1. Proc Natl Acad Sci USA 2003; 100: 10411-10416.
28. Camargo JF, Quinones MP, Mummidi S, Srinivas S, Gaitan AA, Begum K et al. CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation. J Immunol 2009; 182: 171-182.
29. Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, Brinkman DM, Kamphuis SS, Van Rossum MA et al. Association of the autoimmunity locus 4q27 with juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 901-904.
30. Hinks A, Ke X, Barton A, Eyre S, Bowes J, Worthington J et al. Association of the IL2RA/CD25 gene with juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 251-257.
31. Packham JC, Hall MA. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41: 1428-1435.
32. Adib N, Hyrich K, Thornton J, Lunt M, Davidson J, Gardner-Medwin J et al. Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study. Rheumatology (Oxford) 2008; 47: 991-995.
33. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991-1994.
34. Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J et al. Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39: 1431-1433.
35. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
36. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J et al. International League of Associations for Rheumatology Classification of Juvenile Idiopathic Arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-392.